Quarterly report pursuant to Section 13 or 15(d)


Cover - shares
6 Months Ended
Jun. 30, 2023
Aug. 11, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2023  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 001-39126  
Entity Registrant Name CNS Pharmaceuticals, Inc.  
Entity Central Index Key 0001729427  
Entity Tax Identification Number 82-2318545  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 2100 West Loop South  
Entity Address, Address Line Two Suite 900  
Entity Address, City or Town Houston  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 77027  
City Area Code 800  
Local Phone Number 946-9185  
Title of 12(b) Security Common Stock  
Trading Symbol CNSP  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   4,201,930